Latest News and Policy Updates from HLC
Stay informed with HLC’s official press releases and media statements on critical healthcare policy issues. From responses to major legislative developments to announcements of new initiatives, these statements reflect HLC’s positions and showcase our voice in national healthcare policy debates.
Media Contact: Sean Brown, 202.701.3110
“Tariffs would critically harm patients” – HLC Highlights Private Sector Actions to Strengthen Healthcare Supply Chain
The Healthcare Leadership Council (HLC), an association of CEOs and C-suite executives from all sectors of healthcare, responded to the Department of Commerce's request for information (RFI) regarding the initiation of a Section 232 National Securit…
Healthcare Leadership Council Names US Chamber Veteran and Seasoned Healthcare Expert Katie Mahoney to Top Policy Post
HLC Board Chair: Hiring reflects strong and growing momentum at HLCWashington, DC, February 26, 2024 – The Healthcare Leadership Council (HLC), the leading health industry association representing all disciplines of American healthcare, today named …
Analysis: Proposed Change in Medicaid Drug Rebate Program Could Affect Drug Pricing, Access in Other Markets
Avalere Report Finds Proposal to “Stack” Drug Discounts in Calculating Medicaid Best Price Could Lead to Disruption for Patients, Pharmacies, Payers, Manufacturers WASHINGTON – A proposal by the Biden Administration to change how prescription drug r…
HLC Opposes Expansion of TRIPS Intellectual Property Waiver to COVID-19 Diagnostics and Therapeutics
In Statement to U.S. International Trade Commission, Health Leaders Say Medical Innovation Likely to “Suffer and Shrink” by Weakening ProtectionsWASHINGTON – In a statement to the U.S. International Trade Commission (USITC), which is conducting hear…
American Healthcare: The Challenge to Stay on Top
The Healthcare Leadership Council hosted a webinar which highlighted the relationship between intellectual property (IP) and innovation, a linkage that is critically important in healthcare. The panel was comprised of: Joe Allen, Executive Director…
Senate Should Refrain from Seeking Drug Price Controls, Health Leaders Say
HLC President: There Are More Effective Ways to Achieve Affordability that Won’t Undermine Future Medical InnovationWASHINGTON – Amidst reports that U.S. Senate Democrats have reached agreements on portions of a reconciliation package that will incl…
Americans Deserve the Full Truth About Medicare-For-All and its Ramifications for their Healthcare
So much of the nation’s discussion about the Medicare-for-all concept takes place through a political prism. It’s important, though, to fully understand what such a drastic change to our healthcare system would mean for patients and the care on whi…
Statement by Healthcare Leadership Council President Mary R. Grealy on Reported Agreement on Drug Pricing Legislation
The reported congressional agreement on changes to Medicare’s drug pricing structure creates a disturbing precedent that will do little to benefit patients but will discourage the capital investment that leads to breakthrough treatments and therapie…
Lawmakers Have a Drug Pricing Solution Right in Front of Them
As Congress continues to deliberate on drug pricing proposals that many would call extreme, even radical – empowering the federal government to set prices instead of having prices negotiated in the marketplace – a leading health policy research firm…
Statement by Healthcare Leadership Council President Mary R. Grealy on Presidential Address on Drug Prices
President Biden is absolutely correct in praising the extraordinary efforts of America’s biopharmaceutical companies in developing vaccines and therapies to combat the COVID-19 pandemic. It cannot be forgotten, though, that millions are still losin…
Why We Don’t Need and Shouldn’t Want a Public Option
Earlier this year, Senator Patty Murray (D-WA), the chair of the Senate Health, Education, Labor and Pensions Committee, and Congressman Frank Pallone (D-NJ), chairman of the House Energy and Commerce Committee, announced their intent to introduce l…
Nation’s Seniors Not Supportive of Giving Federal Government Greater Control of Medicare Drug Prices, Polling Shows
WASHINGTON – Proposals in Congress to give the federal government power to set prices for medications in the Medicare Part D prescription drug program are not getting an enthusiastic reception from program beneficiaries, according to a nationwide su…
Explore Our Policy Agenda
With a unified voice spanning the entire healthcare continuum, HLC is driving meaningful policy change to enhance the future of the U.S. healthcare system.
